Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
The DOI matches its Crossref record; 493 of the 493 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMechanisms of Drug Release in Nanotherapeutic Delivery SystemsPamela T. Wong and Seok Ki Choi*View Author Information Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States*E-mail: [email protected]. Tel.: (734) 647-0052. Fax: (734) 936-2990.Cite this: Chem. Rev. 2015, 115, 9, 3388–3432Publication Date (Web):April 27, 2015Publication History Received22 August 2014Published online27 April 2015Published inissue 13 May 2015https://pubs.acs.org/doi/10.1021/cr5004634https://doi.org/10.1021/cr5004634review-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views14486Altmetric-Citations396LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Drug release,Molecules,Organic compounds,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some authors evaluated the encapsulation efficiency of volatile hydrophilic compounds by Gas Chromatography, since, as a result of drug-polymeric micelle interactions, a decrease of the amount of free volatile compounds in bulk water was found [114].”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [114]
Citations
Cites
1 retracted
Gui, R., Wan, A., Liu, X.-F., & Jin, H. (2014) · Chemical Communications · doi:10.1039/c3cc47981a · Cited by 52
RetractedDaniel, M.-C., & Astruc, D. (2004) · Chemical Reviews · doi:10.1021/cr030698+ · Cited by 12,446
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Tasis, D., Tagmatarchis, N., Bianco, A., & Prato, M. (2006) · Chemical Reviews · doi:10.1021/cr050569o · Cited by 4,273
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
Self-citation
Research works printed but not linked: 47
- Majoros I. J., 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 502
- Fischer M., 1999, Angew. Chem., Int. Ed., 38, 884, 10.1002/(sici)1521-3773(19990401)38:7<884::aid-anie884>3.0.co;2-k · DOI · Paper page
- Maeda H., 1989, Crit. Rev. Ther. Drug Carrier Syst., 6, 193
- Raha S., 2010, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 3, 269
- Bhaskar V., 2003, Cancer Res., 63, 6387
- Hong S., 2007, Chem. Biol. (Oxford, U. K.), 14, 107
- Choi Y., 2005, Chem. Biol. (Oxford, U. K.), 12, 35
- Yellepeddi V. K., 2009, Anticancer Res., 29, 2933
- Maturo J., 1988, Biochem. Pharmacol. (Amsterdam, Neth.), 37, 3755
- de Groot F. M. H., 2002, Mol. Cancer Ther., 1, 901
- Bosnjakovic A., 2011, Nanomedicine (N. Y., NY, U. S.), 7, 284
- Levy G. A., 2006, Hepatology (Hoboken, NJ, U. S.), 43, 581
- Mahajan S. D., 2012, Methods in Enzymology, 509
- Salvi A., 1997, Drug Metab. Dispos., 25, 395
- Sanghani S. P., 2003, Clin. Cancer Res., 9, 4983
- Yoon K. J. P., 2003, Mol. Cancer Ther., 2, 1171
- Tougou K., 1998, Drug Metab. Dispos., 26, 355
- Barnes K. R., 2004, Chem. Biol. (Oxford, U. K.), 11, 557
- DeFeo-Jones D., 2000, Nat. Med. (N. Y., NY, U. S.), 6, 1248
- Wong B. K., 2001, Drug Metab. Dispos., 29, 313
- Hervio L. S., 2000, Chem. Biol. (Oxford, U. K.), 7, 443
- Silver D. A., 1997, Clin. Cancer Res., 3, 81
- Felsen C. N., 2014, Am. J. Physiol.: Lung Cell. Mol. Physiol., 306, L764
- Butler P. J., 1967, Biochem. J., 103, 78b
- Schmalfeldt B., 2001, Clin. Cancer Res., 7, 2396
- Incorvaia L., 2007, Anticancer Res., 27, 1519
- Trail P. A., 1992, Cancer Res., 52, 5693
- Hinman L. M., 1993, Cancer Res., 53, 3336
- Mahmud N. P., 1998, Anti-Cancer Drug Des., 13, 655
- Hunter F. W., 2012, Biochem. Pharmacol. (Amsterdam, Neth.), 83, 574
- van Haaften R. I. M., 2001, Biochem. Pharmacol. (Amsterdam, Neth.), 61, 715
- Rodrigues M. L., 1995, Cancer Res., 55, 63
- Rodrigues M. L., 1995, Chem. Biol. (Oxford, U. K.), 2, 223
- Goard M., 2005, Chem. Biol. (Oxford, U. K.), 12, 685
- Chourasia M. K., 2003, J. Pharm. Pharm. Sci., 6, 33
- Berchane N. S., 2007, Int. J. Pharm. (Amsterdam, Neth.), 337, 118
- Zhang M., 2011, Int. J. Nanomed., 6, 2337
- Kommareddy S., 2007, Nanomedicine (N. Y., NY, U. S.), 3, 32
- Mitran R.-A., 2014, Cent. Eur. J. Chem., 12, 1
- Wu C., 2011, Int. J. Pharm. (Amsterdam, Neth.), 403, 162
- Nelson J. L., 2002, Cancer Res., 62, 7280
- Li C., 1998, Cancer Res., 58, 2404
- Seymour L. W., 2002, J. Clin. Oncol., 20, 1668, 10.1200/jco.2002.20.6.1668 · doi:10.1200/jco.2002.20.6.1668 · Paper page
- Vasey P. A., 1999, Clin. Cancer Res., 5, 83
- Yokoyama M., 1991, Cancer Res., 51, 3229
- Wosikowski K., 2003, Clin. Cancer Res., 9, 1917
- Yurkovetskiy A., 2010, Cancer Res., 70
Cited by
Items 501–512 of 512
Colon Cancer Traitement using Proteins based Nanoparticles containing Curcumin as active molecule
Alrushaid, N. (2025) · theses.fr (ABES) · doi:10.70675/303f8429zfa49z44d9z8e92z17029c98a624
Gu, X., Sun, L., Zhang, H., Liu, G. S., Cui, Y., Zhou, W. J., Wang, Q., Xie, C., & Fan, Q. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb00913a
Dual-stimuli-responsive nanocarriers for biomedical application
Abishek, K. G., Pawar, N., Manu, K. R., Leharwani, M., Sarangi, P. K., Gupta, G., Sahebkar, A., Kesharwani, P., & Dandela, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00020-8
Azo-based compounds for hypoxia-responsive drug delivery
Nasiri, S., & Najjar, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00015-4
Kunjiappan, S., Pavadai, P., Muraleedharan, D., Dinesh, B. G. H., & Murugesan, S. (2026) · ChemistrySelect · doi:10.1002/slct.74002
Parasar, S., Kantesaria, R., & Panda, H. S. (2026) · ChemistrySelect · doi:10.1002/slct.74582 · Cited by 1
Biocompatible biodegradable polymers for drug release by supercritical technology
Pal, S., & Varshney, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21459-2.00002-0
Wang, M., Chen, J., 吴中华, Wang, Z., Zhong, Z., & Zhong, Y. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.101014
Arumugam, S., Lin, N., Zhao, C., Xie, J., & Popik, V. V. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c18307
Shanker, Y. R., Fathima, J. H. S., Govindarajan, P., Balakrishnan, B., Baskaran, K., & Subbaraj, G. K. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100842
Small molecule drug conjugates: Design principles, therapeutic applications, and clinical progress
Sanapalli, B. K. R., Gopalakrishnan, J., Deshpande, A. S., & Sanapalli, V. (2026) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2026.09.002
Pan, W., Chen, X., Li, M., Bao, Q., Fu, Z., Wang, X., Wang, X., Xu, Y., Chen, J., Ding, B., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110739
Metadata
- Authors
- Wong, P. T., & Choi, S. K.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Choi, Seok Ki
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-27
- Volume
- 115
- Issue
- 9
- Pages
- 3388-3432
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2053890812
- Cited by
- 507
- References
- 493
- Citations by year
- 2026: 28 · 2025: 35 · 2024: 31 · 2023: 45 · 2022: 35 · 2021: 51 · 2020: 59 · 2019: 64 · 2018: 60 · 2017: 48 · 2016: 40 · 2015: 11
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office of the Vice President for Research, University of Michigan
- Shanghai Jiao Tong University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug release mechanism, nanomedicine, controlled drug release, anticancer agents, nanocarriers
- MeSH terms
- Theranostic Nanomedicine, Animals, Drug Carriers, Humans, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.